Table 2: Medical complications among the study population.
|
|
Total (N = 110) |
≤ 50 years (N = 25) |
> 50 years (N = 58) |
p value |
|
Metabolic |
||||
|
Hyperglycemia* |
52 (47%) |
11 (44%) |
41 (48%) |
0.709 |
|
Hyponatremia** |
82 (75%) |
22 (88%) |
60 (78%) |
0.079 |
|
Hypernatremia*** |
2 (2%) |
0 (0%) |
2 (2%) |
0.439 |
|
Infections |
||||
|
Respiratory |
37 (34%) |
5 (20%) |
32 (38%) |
0.101 |
|
Gastrointestinal |
2 (2%) |
1 (4%) |
1 (1%) |
0.353 |
|
Urinary tract |
12 (11%) |
2 (8%) |
10 (12%) |
0.596 |
|
Renal failure |
15 (14%) |
3 (12%) |
12 (14%) |
0.786 |
|
DVT |
4 (4%) |
1 (4%) |
3 (4%) |
0.912 |
|
CV |
11 (10%) |
5 (20%) |
6 (7%) |
0.058 |
Values are expressed as numbers (%).
CV: Cardiovascular complications such as arrhythmia, heart failure and coronary artery disease, DVT: Deep Venous Thrombosis.
Patients may have more than one complication
*Hyperglycemia is defined as random plasma glucose > 140 mg/dl; **Hyponatremia is defined as serum Sodium < 135 mmol/l; ***Hypernatremia is defined as serum Sodium > 145 mmol/l